Gleason P P, Schulz R, Smith N L, Newsom J T, Kroboth P D, Kroboth F J, Psaty B M
Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, PA 15261, USA.
J Gen Intern Med. 1998 Apr;13(4):243-50. doi: 10.1046/j.1525-1497.1998.00074.x.
To describe the prevalence of benzodiazepine use, sociodemographic and physical health factors associated with use, dosages taken, and directions for use among individuals aged 65 years and older.
Cross-sectional analysis of baseline data from the community-based, prospective observational Cardiovascular Health Study.
PATIENTS/PARTICIPANTS: Medicare eligibility lists from four U.S. communities were used to recruit a representative sample of 5,201 community-dwelling elderly, of which 5,181 participants met all study criteria.
Among participants, 511 (9.9%) were taking at least one benzodiazepine, primarily anxiolytics (73%). Benzodiazepines were often prescribed to be taken pro re nata (PRN "as needed"), and 36.5% of prescriptions with instructions to be taken regularly were taken at a dose lower than prescribed. Reported over-the-counter (OTC) sleep aid medication use was 39.2% in benzodiazepine users and 3.3% in nonusers. In a multivariate logistic model, the significant independent correlates of benzodiazepine use were being white (odds ratio [OR] 1.9; 95% confidence interval [CI] 1.0, 3.4), female (OR 1.7; CI 1.4, 2.2), and living in Forsyth County, North Carolina, or Washington County, Maryland, compared with living in Sacramento County, California, or Allegheny County, Pennsylvania (OR 2.3; CI 1.4, 2.2); having coronary heart disease (OR 1.6; CI 1.2, 2.1), health status reported as poor or fair (OR 1.8; CI 1.4, 2.3), self-reported diagnosis of nervous or emotional disorder (OR 6.7; CI 5.1, 8.7), and reporting use of an OTC sleep aid medication (OR 18.7; CI 14.1, 24.7).
One in 10 participants reported taking a benzodiazepine, most frequently an anxiolytic, often at a lower dose than prescribed and usually PRN. The high prevalence of OTC sleep aid medication and benzodiazepine use may place the patient at increased risk of psychomotor impairment. Physicians should assess OTC sleep aid medication use when prescribing benzodiazepines.
描述65岁及以上人群中苯二氮䓬类药物的使用情况、与使用相关的社会人口统计学和身体健康因素、服用剂量及使用说明。
对基于社区的前瞻性观察性心血管健康研究的基线数据进行横断面分析。
患者/参与者:使用来自美国四个社区的医疗保险资格名单招募了5201名社区居住老年人的代表性样本,其中5181名参与者符合所有研究标准。
在参与者中,511人(9.9%)正在服用至少一种苯二氮䓬类药物,主要是抗焦虑药(73%)。苯二氮䓬类药物通常按需要服用,在有定期服用说明的处方中,36.5%的服用剂量低于规定剂量。苯二氮䓬类药物使用者中报告使用非处方(OTC)助眠药物的比例为39.2%,非使用者中为3.3%。在多变量逻辑模型中,苯二氮䓬类药物使用的显著独立相关因素包括:白人(比值比[OR]1.9;95%置信区间[CI]1.0,3.4)、女性(OR 1.7;CI 1.4,2.2),与居住在加利福尼亚州萨克拉门托县或宾夕法尼亚州阿勒格尼县相比,居住在北卡罗来纳州福赛斯县或马里兰州华盛顿县(OR 2.3;CI 1.4,2.2);患有冠心病(OR 1.6;CI 1.2,2.1)、自我报告健康状况为差或一般(OR 1.8;CI 1.4,2.3)、自我报告诊断为神经或情绪障碍(OR 6.7;CI 5.1,8.7)以及报告使用非处方助眠药物(OR 18.7;CI 14.1,24.7)。
十分之一的参与者报告服用苯二氮䓬类药物,最常见的是抗焦虑药,通常服用剂量低于规定剂量且通常按需要服用。非处方助眠药物和苯二氮䓬类药物的高使用率可能使患者发生精神运动障碍的风险增加。医生在开具苯二氮䓬类药物处方时应评估非处方助眠药物的使用情况。